Dianthus Therapeutics
DNTH
DNTH
97 hedge funds and large institutions have $366M invested in Dianthus Therapeutics in 2021 Q2 according to their latest regulatory filings, with 16 funds opening new positions, 39 increasing their positions, 22 reducing their positions, and 9 closing their positions.
Holders
97
Holders Change
+7
Holders Change %
+7.78%
% of All Funds
1.69%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
16
Increased
39
Reduced
22
Closed
9
Calls
$1K
Puts
–
Net Calls
+$1K
Net Calls Change
-$556K
Top Buyers
1 |
GPP
1
Great Point Partners
Greenwich,
Connecticut
|
$10.9M |
2 |
O
2
OrbiMed
New York
|
$19.9M |
3 |
ACM
3
Aquilo Capital Management
San Francisco,
California
|
$26.3M |
4 |
4
Principal Financial Group
Des Moines,
Iowa
|
$4.65M |
5 |
5
BlackRock
New York
|
$20.8M |